Verona, Italy

Multidisciplinary Management of Prostate Cancer

The course is aimed at radiation oncologists, urologists, medical oncologists and other specialists and trainees who have a special interest in prostate cancer and are willing to update their knowledge.

FACULTY

Course director 

  • Jochen Walz, Urologist, Institut Paoli-Calmettes, Marseille (FR) 
  • Valérie Fonteyne, Radiation Oncologist, Ghent University Hospital, Ghent (BE)

Teachers 

  • Ferran Algaba, Pathologist, Autonomous University of Barcelona, Barcelona (ES) 
  • Alison Tree, Radiation Oncologist, Ghent University Hospital, Ghent (BE)
  • Phillipe Cornford, Consultant Urological Surgeon, Bon Secours Hospital, Cork (IE); Honorary Professor, University of Liverpool (UK)
  • Alfonso Gomez de Iturriaga, Radiation Oncologist, Cruces University Hospital, Baracaldo (ES) 
  • Geert Villeirs, Radiologist, Ghent University Hospital, Ghent (BE) 
  • Henk van der Poel, Urologist, Netherlands Cancer Institute, Amsterdam (NL)

Delineation administrator

  • Berardino de Bari, Radiation Oncologist, Le Réseau Hospitalier Neuchâtelois, Neuchâtel (CH)

Local organiser

  • Prof. Filippo Alongi, Radiation Oncologist, IRCCS Sacro Cuore Don Calabria Hospital Negrar-Verona, University of Brescia (I

 

This 4-day teaching course aims at focusing on the management of localised, locally advanced and metastatic prostate cancer. It emphasises the importance of a multidisciplinary approach and of teamwork, where full information exchange is vital to provide the best up-to-date scientific evidence on which the management of the disease will be based. This will be illustrated during state-of-the-art lectures presented by experts in the field, covering important issues such as biology, imaging, pathology, therapy and future developments. Interactive case studies and journal clubs will be integrated on a daily basis and there will be ample time for open discussions amongst participants and experts. A special session on target delineation for radiotherapists will also be organised during the course.

Learning outcomes

  • To provide an in-depth overview of the epidemiology, pathology, imaging and treatment options for low, intermediate and high risk prostate cancer 
  • To discuss patient selection/indications and contra-indications for the various treatment options
  • To provide a critical overview of the surgical and radiotherapy techniques available for the management of prostate cancer  
  • To discuss the new drugs currently available for the management of the advanced and metastatic stages of the disease
  • To debate on the most recent developments relevant to prostate cancer management.

Course content

  • Normal prostate: anatomy – embryology, histology
  • Prostate cancer: epidemiology and prevention, clinical diagnosis, imaging modalities pathology, staging
  • prostate cancer management according to risk groups: active surveillance, surgery, radiotherapy
  • External beam radiotherapy: on-line control, target delineation
  • Toxicity of radiotherapy: acute and late morbidity – erectile dysfunction
  • Role of surgery and its morbidity
  • Alternative treatments
  • Adjuvant and salvage radiotherapy after radical surgery
  • Rising PSA after surgery and after radiotherapy
  • Imaging for recurrent detection
  • Node positive prostate cancer
  • Hormone sensitive metastatic prostate cancer
  • Castration resistant prostate cancer
  • Palliative radiotherapy and surgery
  • Non systemic treatment in the metastatic setting.
  • Case discussions

 

Prerequisites

Before commencing this course participants should:  

  • Revise the general principles of prostate cancer epidemiology, pathology, diagnosis and staging
  • Read the published ESTRO and ASTRO guidelines on prostate contouring and the EAU/ESTRO/SIOG/EANM/ESUR guidelines on prostate cancer
  • Complete the FALCON* exercise which is distributed prior to the course.

Teaching methods

  • 21 hours lectures
  • 3 hours contouring
  • 4 hours practical workshops
  • 5 hours interactive discussions.

The course consists of didactic lectures, interactive sessions (clinical case discussions and Journal Clubs) and practical demonstrations.

Methods of assessment

  • In-class voting
  • Delineation exercise  

Accreditation

Application for CME recognition will be submitted to the European Accreditation Council for Continuing Medical Education (EACCME), an institution of the European Union of Medical Specialists (UEMS). EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA). Information on the status of the applications can be obtained from the ESTRO office.

A draft of the scientific programme will be available soon.

Crowne Plaza Verona – Fiera

Via Belgio16

37135 Verona VR

Italy

Membership

ESTRO members can order products at substantially reduced prices. To benefit from the member registration rate, you must subscribe for the ESTRO membership 2025 BEFORE registering to the course. To become an ESTRO member, benefit from the member registration rate and discover the many other member advantages, please visit the membership page.

Fees

 

Early rate

Late rate

Non-Members

  850 EUR

 950 EUR

ESTRO Members

  675 EUR 

 825 EUR

In-training members*

  525 EUR

 675 EUR

* Members with specialty RadiationTherapist (RTT) may register at the In-Training fee

The fee includes the course material, coffees, lunches, and the social event.

Advance registration & payment are required.

Access to homework and/or course material will become available upon receipt of full payment.

Insurance and cancellation

Participants are strongly advised to take out their own personal insurance policy. ESTRO does not accept liability for individual medical, travel or personal accidents or incidents. Participants are strongly advised to take insurance policies to cover flight and accommodation cancellation penalties. ESTRO will not refund any travel or accommodation expenses.

For any cancellation made by the course or workshop participant, ESTRO School Events Cancellation Policy will be followed and all stated penalty fees will be applied.

Reduced fees

Members from emerging countries may register at a preferential rate of 350 Euro. Emerging country fee applies to individuals from low-income and lower-middle-income economies according to the World Bank listing here.

Additionally, all specialties from the following countries can benefit from this preferential rate: Albania, Belarus, Bosnia and Herzegovina, Bulgaria, Hungary, Macedonia, Moldova, Montenegro, Romania, Russian Federation, Serbia, Turkey, Ukraine.

The preferential rate of 350 Euro is granted automatically when you click on the  BOOK NOW  button and the three conditions below are met:

  1. Only ESTRO members for 2025 are eligible (please make sure your 2025 membership is in order before you click on the BOOK NOW  button)
  2. Only one course per person per year can be subsidized by ESTRO
  3. Sponsored candidates are not entitled to reduced fees (the invoicing address has to be the one of the participant)  

 Please note:

  • We can only guarantee a certain number of reduced fees per course
  • Application deadlines are the same as early registration fees